Skip to main navigation
Skip to search
Skip to main content
Bar-Ilan University Home
Help & FAQ
Link opens in a new tab
Search content at Bar-Ilan University
Home
Researchers
Organisations
Research output
Prizes
Student theses
Courses
Activities
Projects
Press/Media
Datasets
Equipment
Risperidone in treatment-refractory schizophrenia
Donna A. Wirshing
, Barringer D. Marshall
, Michael F. Green
, Jim Mintz
, Stephen R. Marder
, William C. Wirshing
Department of Computer Science
Department of Veterans Affairs
Research output
:
Contribution to journal
›
Article
›
peer-review
147
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Risperidone in treatment-refractory schizophrenia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Risperidone
100%
Treatment-resistant Schizophrenia
100%
Haloperidol
60%
Clinical Efficacy
20%
Brief Psychiatric Rating Scale
20%
Tardive Dyskinesia
20%
Akathisia
20%
Positive Symptoms
10%
Placebo
10%
Flexible Dose
10%
Baseline Characteristics
10%
Clinical Safety
10%
Positive Psychotic Symptoms
10%
Fixed-dose Combination
10%
Group 11
10%
Neuromotor
10%
Washout Period
10%
Extrapyramidal Side Effects
10%
Clinical Change
10%
Conceptual Disorganization
10%
Dose Comparison
10%
Pharmacology, Toxicology and Pharmaceutical Science
Risperidone
100%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
60%
Tardive Dyskinesia
20%
Akathisia
20%
Disorientation
10%
Comparison Trial
10%
Placebo
10%
Positive Syndrome
10%
Symptom
10%
Extrapyramidal Symptoms
10%
Cholinergic Receptor Blocking Agent
10%